Recurrent ovarian cancer

Jayanta Chatterjee(Imperial College Healthcare NHS Trust), Sarah P. Blagden(Churchill Hospital), Christina Fotopoulou(Ovarian Cancer Action), Henry C Kitchener(University of Manchester), Viren Asher

Unknown

January 1, 2015

10.1093/med/9780199654994.003.0023

Cited by 2

Related Papers

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

|Nature reviews. Cancer|2015|1.4k

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

|Annals of Oncology|2013|1.1k

<scp>FIGO</scp> staging of endometrial cancer: 2023

|International Journal of Gynecology & Obstetrics|2023|926

Management of women who test positive for high-risk types of human papillomavirus: the HART study

|The Lancet|2003|505

ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease

|Annals of Oncology|2024|277